CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson’s Disease

Journal of Medicinal Chemistry 2026 Open access

Read full text

Authors: Xiaochen Tian, Saghir Ali, John A. Allen, Jia Zhou

DOI: 10.1021/acs.jmedchem.6c00866

Cited by: 2

References: 34

Fields of Study & Subjects

Receptor Mechanisms and Signaling Diabetes Treatment and Management Parkinson's Disease Mechanisms and Treatments

References 34